HOLLY A SHILL
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology PHOENIX, AZ NPI 1922034636
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology AZ MITSUBISHI TANABE PHARMA AMERICA, INC. All categories
General Payments — all program years on this page
$56,895.85
- Category: General Payments
- Program years: PY2018–2024
- Record count: 109
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,322.96 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,600.00 | 2 |
| Food and Beverage | $722.96 | 5 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $1,250.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $612.10 | 3 |
| Supernus Pharmaceuticals, Inc. | $290.07 | 1 |
| Abbott Laboratories | $170.79 | 2 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092668337 | Boston Scientific Corporation | $80.14 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092668339 | Boston Scientific Corporation | $181.96 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092668341 | Boston Scientific Corporation | $350.00 | 09/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1125337588 | Abbott Laboratories | $4.84 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125337590 | Abbott Laboratories | $165.95 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144509252 | MITSUBISHI TANABE PHARMA AMERICA, INC. | $1,250.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1147876579 | Supernus Pharmaceuticals, Inc. | $290.07 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.